Clinical Trials Browser

Phase 1/2 × Terminated × Leukemia, Lymphoid × Clear all

NCT05272813 2024-07-18

A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL

Phase 1/2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Leukemia, Lymphocytic, Chronic, B-Cell